°®¶¹´«Ã½

Georgia World Congress Center 

285 Andrew Young International Blvd NW, 

Atlanta, Ga. 30313 

ASM membership is not required to submit or present an abstract. However, membership is required to apply for and receive an ASM Award or Travel Grant.

There is no fee to submit an abstract at this time.

Presenting authors may submit up to 3 unique abstracts. Only 1 abstract may be presented each day. If you have 3 abstracts accepted, you will have 1 presentation scheduled over 3 days on Friday, June 14, Saturday, June 15 and Sunday, June 16.

For technical support, contact: asm@support.ctimeetingtech.com, 217-398-1792. Support hours are Monday-Friday, 8 a.m.-5 p.m. CT.

An Early Abstract is a mechanism for abstract submitters who need an early decision for a VISA to submit and be reviewed, with a decision no later than Dec. 19, 2023. To utilize this option, choose Early Abstract when submitting. Early Abstract submission closes Dec. 5, 2023, 12 p.m. ET.
 
Regular Abstracts may be submitted by Jan. 23, 2024, 12 p.m. ET. They will be reviewed in the regular window with dispositions being sent on/around Feb. 28, 2024.  

For a meeting of this size, it is not possible to consider special scheduling requests. If 2 or more abstracts are scheduled at the same time, you are invited to have a co-author present 1 of the abstracts.

Yes, ASM considers the submitting author to be the presenting author. Contact information is collected for the submitter and the presenting author. ASM will only correspond with the presenting author of the accepted abstract. This policy ensures that the presenter knows when and where to present the abstract.

Note: If you and a colleague are both submitting an abstract, there is no guarantee that both will be placed into the same session(s), if accepted. Due to the size of the meeting and the number of presentations, we will not accept special scheduling requests for abstract presentations.

Authors can be updated up to the submission deadline. Requests after this date will not be accommodated.

Yes. If you and your co-authors come from more than 1 affiliation, be sure to type common affiliations in exactly the same manner. Review the author block when displayed to see if the correct numbers of affiliations are displayed.

Your abstract may be written without the use of the following bolded headers: Background, Materials, Results, Conclusion. However, follow the abstract guidelines to ensure all required information about your study is provided in your abstract.  

We recommend that you prepare and save a copy of your abstract in your personal electronic files before going to ASM’s web page. After your submission is complete, you will receive a confirmation email.

All ASM Microbe abstracts will be embargoed until May 13, 2024. Late-breaking abstracts will be embargoed to coincide with the times they are presented at the meeting. Embargo times and dates will be clearly marked on all press releases. 

Additionally, press releases and other promotional activity by third parties must coincide with the date and time of the presentation. 

When asking for outside comments on press releases or news stories before the embargo has lifted, journalists are requested to ensure that the embargo is respected. ASM reserves the right to ban any journalist from the meeting who breaks the embargo or breaches the media policy in any other way. 

If your research has already been published, please contact the ASM communications office to discuss how to handle promoting your abstract at communications@asmusa.org. 

Yes. Your abstract may have a maximum limit of 2,200 characters, which does not include tables/graphics or spaces. Title, authors, groups and institutions do not count toward the character count maximum. 
 
A Times New Roman Font is recommended. Avoid use of fonts specific to the software application you use. This is particularly true for symbols, as some character sets do not translate well, resulting in lost information. 
 
Note: An additional entry line has been added to the electronic submission to accommodate credits, footnotes, etc.; a character limit of 300 is applied to this field but does not count toward the character count of the abstract body.

You apply for a travel award via the abstract submission site. To be considered for a travel award, in addition to each award’s specific eligibility qualifications, you must have a complete, accepted abstract. However, this does not guarantee you a travel award.  
 
There is a separate review process and travel award dispositions will be sent on/about Feb. 28, 2024. If selected, you are only eligible to receive 1 travel award per abstract submitter.

The Abstract Submission system will provide a control number as soon as you complete the affirmations and provide a title for your abstract. As you complete individual steps in the process, the system will display the results. At the end of the process, a final summary page will be immediately displayed with all information successfully received. You may edit your abstract until the submission deadline of Jan. 23, 2024, 12 p.m. ET. No further changes can be made after submission closes. Your abstract must show as complete or finalized when submission closes in order to move to the review stage. Incomplete abstracts will not be reviewed.
 

No. If your abstract is "Complete," it means you have completed all the steps required to be reviewed. Abstracts are assigned to the reviewers in January. Disposition letters will be e-mailed to submitters  
on/about Feb. 28, 2024.

No. Programming decisions are final.

Yes, all abstract presenters must register for the meeting no later than Monday, April 1. Failure to register by April 1, 2024, will result in the withdrawal of your abstract from the scientific program.

 

No, all presentations are expected to be made in person.  In-person attendance is required. ePosters are available only as a complement to in-person presentations, they are not offered in lieu of in-person presentations.

 

If you are unable to secure a visa in time for travel to the meeting, and you do not have a co-author who can present in your absence, you must withdraw your abstract. If you do not receive visa status by April 1, you must register for the meeting, or your abstract will be withdrawn. Registration may be cancelled by May 14 to receive a full refund. The $50 cancellation processing fee will be waived with proof of visa denial letter. All cancellations must be emailed to microbe@maritz.com and received by May 14, 2024. After this date, registration refunds will not be issued due to inability to secure a visa.

To withdraw your abstract without incurring a penalty, you must do so by April 1, 2024. You can withdraw your abstract by sending an email to asmmicrobemtgprogram@asmusas.org, referencing the control number of the abstract you wish to withdraw.

Encore abstracts are not permitted, however, ASM will consider "adapted" or "repurposed" submissions that overlap with the original abstract but contain new/additional data, analyses and/or interpretations. It is the responsibility of the author to verify copyright with the organizer of the meeting where the original abstract was presented.
 

 

• Abstracts that are general descriptions of a new product.
• Abstracts that read like advertisements.
• Abstracts that are a general description of managerial innovation.
• Case reports (unless truly remarkable).

 

 

This information will be provided closer to the date of the conference.   

 

Plagiarism will not be tolerated in submitted abstracts. All submitted abstracts identified with plagiarism will be sent to the program committee for review and handling.   

The NIH ORI publication.

  

 

The full online is available. 

  

 

All information related to your abstract submission is available in your within the Tasks tab.